2020
DOI: 10.2147/ott.s281211
|View full text |Cite
|
Sign up to set email alerts
|

<p>miR-27b Suppresses Tongue Squamous Cell Carcinoma Epithelial–Mesenchymal Transition by Targeting ITGA5</p>

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
13
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 17 publications
(14 citation statements)
references
References 29 publications
1
13
0
Order By: Relevance
“…miR-27b has been reported to be a tumor suppressor gene. miR-27b can inhibit epithelial-mesenchymal transition andinhibit the proliferation and migration of oral squamous cell carcinoma by targeting integrin subunit α5( 11 ). In addition, miR-27b inhibited the growth and metastatic behavior of ovarian cancer cells by targeting C-X-C motif chemokine ligand 1( 12 ).…”
Section: Resultsmentioning
confidence: 99%
“…miR-27b has been reported to be a tumor suppressor gene. miR-27b can inhibit epithelial-mesenchymal transition andinhibit the proliferation and migration of oral squamous cell carcinoma by targeting integrin subunit α5( 11 ). In addition, miR-27b inhibited the growth and metastatic behavior of ovarian cancer cells by targeting C-X-C motif chemokine ligand 1( 12 ).…”
Section: Resultsmentioning
confidence: 99%
“…The experimental methods and reagents were introduced in our previous studies. 20 The primary antibodies used in this study were as follows, cyclin A2 (ab181591), c-Myc (ab32072), E2F2 (ab138515) and GAPDH (ab181602). The bands were finally analyzed by the ImageJ software.…”
Section: Methodsmentioning
confidence: 99%
“…Micro-RNAs (miRNAs) are not only important regulators of cell proliferation, differentiation, and apoptosis but also closely related to cell phenotype and human diseases [15]. Emerging evidence has indicated that upregulated miR-27b-5p (miR-27b) and miR-92a-1-3p (miR-92a) levels contribute to various types of cancers [16][17][18][19]. e overexpression of miR-92a has been shown to promote cellular activity and suppress the sensitivity of lung cancer cells to gefitinib [20][21][22][23].…”
Section: Introductionmentioning
confidence: 99%